Literature DB >> 22044741

Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine.

Xiaojuan Zhao1, Yunpeng Fan, Deyun Wang, Yuanliang Hu, Liwei Guo, Shiliang Ruan, Jing Zhang, Ju Yuan.   

Abstract

The aim of this study is to investigate whether the activity of inducing immune response of glycyrrhetinic acid (GA) could be enhanced after GA was encapsulated with liposome. Three hundred and fifty 14-day-old chickens were randomly assigned to 7 groups and vaccinated with Newcastle disease (ND) vaccine. Simultaneously, the chickens in experimental groups were injected with the glycyrrhetinic acid liposome (GAL) at three doses, GA and blank liposome, respectively. The activity of serum antibody titer, concentrations of immunoglobulins G (IgG) and immunoglobulins M (IgM), lymphocytes proliferation, the proportions of lymphocyte subpopulations (CD4(+) and CD8(+)) was determined after vaccination. GAL was evaluated for inducing humoral immunity and cellular immunity in chicken against Newcastle disease (ND) vaccine. The results showed that GAL not only could significantly enhance the antibody titers, IgG and IgM in ND vaccine immunized chicken, but also significantly promote the lymphocyte proliferation and the proportions of CD4(+) and CD8(+), as comparison with GA, BL and VC control groups. Moreover, the effects appear a dose-dependent manner and a time-dependent manner. These indicated that GAL could significantly promote the activation potential of humoral immunity and cellular immunity in chicken and present certain dose-effect and time-effect relationships. The formulations of GA and liposome can further enhance the immune response against ND vaccine compared with the adjuvant alone.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044741     DOI: 10.1016/j.vaccine.2011.10.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Liposomes as vaccine delivery systems: a review of the recent advances.

Authors:  Reto A Schwendener
Journal:  Ther Adv Vaccines       Date:  2014-11

2.  Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.

Authors:  Shanshan Liu; Wei Sun; Jun Chu; Xiufen Huang; Zongxue Wu; Minxin Yan; Qiang Zhang; Peng Zhao; Joseph U Igietseme; Carolyn M Black; Cheng He; Yongqing Li
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

3.  A Novel Adjuvant "Sublancin" Enhances Immune Response in Specific Pathogen-Free Broiler Chickens Inoculated with Newcastle Disease Vaccine.

Authors:  Yangke Liu; Jiang Zhang; Shuai Wang; Yong Guo; Tao He; Rui Zhou
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

4.  Optimization on preparation condition of propolis flavonoids liposome by response surface methodology and research of its immunoenhancement activity.

Authors:  Ju Yuan; Yu Lu; Saifuding Abula; Yuanliang Hu; Jiaguo Liu; Yunpeng Fan; Xiaojuan Zhao; Deyun Wang; Xu Liu; Cui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

5.  The Adjuvant Activity of Epimedium Polysaccharide-Propolis Flavone Liposome on Enhancing Immune Responses to Inactivated Porcine Circovirus Vaccine in Mice.

Authors:  Yunpeng Fan; Liwei Guo; Weifeng Hou; Chao Guo; Weimin Zhang; Xia Ma; Lin Ma; Xiaoping Song
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-03       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.